Correlation analysis of HER2 expression with clinicopathological features and prognosis based on data from 444 patients with urothelial carcinoma
HER2 is highly expressed in UC patients in the Fujian region, correlating with aggressive clinicopathological features. It can serve as a reliable biomarker for predicting recurrence risk, guiding postoperative management and targeted therapy selection.
Authors
- Hanjun Huang (ORCID: https://orcid.org/0000-0002-1808-7189)
- Liefu Ye
- Jiawen Wang
- Xiaorui Li
- Jinfeng Wu
- Yongbao Wei
- Jingyi Luo
- Lihang Chen
- Ziyi Cheng
- Zhixun Guo
Institutions
- Fujian Medical University (CN)
- Fuzhou Second Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1186/s12894-026-02088-3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00